CARVESIN-6.25 – Shince Pharmaceuticals

CARVESIN-6.25

CARVESIN-6.25

Customer Review 0

Rated 5 out of 5

INDICATION & USE

• Post-MI LV Dysfunction

• Mild to severe CHF (NYHA I-IV)

Share it :

Description
Reviews (0)

Description

Composition:

Each uncoated tablet contains :

Carvedilol IP 6.25 mg

Colour : Quinoline Yellow

INDICATION & USE

• Post-MI LV Dysfunction

• Mild to severe CHF (NYHA I-IV)

Reviews

There are no reviews yet.

Be the first to review “CARVESIN-6.25”